We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A welfare benefit plan has sued GlaxoSmithKline (GSK), alleging the company abused the citizen petition process to delay the introduction of a generic version of its blockbuster allergy drug Flonase.